The Industry Standard: Intelligence for the Information Economy

  September 5, 2001
  NEWS & ANALYSIS
   Headlines
   Money & Markets
   Tech & Telecom
   Media & Marketing
   Metrics & Stats
   Policy & Politics
  SEARCH
   
  advanced search
  SERVICES
   Company Index
   Newsletters
   Wireless
  PRINT EDITION
   Read the Magazine

Home > Company Index > Drugs > Biotechnology-Medicine > Pharmos Corporation

Pharmos Corporation
Nasdaq (SC): PARS
Change
symbol:
     
 PROFILE
Pharmos is focused on helping people see and think more clearly. The company develops products to treat ophthalmic, central nervous system (CNS), and neurological conditions. Its two approved products, Lotemax and Alrex, are marketed by Bausch & Lomb in the US. Lotemax is a topical steroid used to treat eye inflammations, and Alrex treats allergic conjunctivitis. Pharmos is also developing Dexanabinol, a neuroprotective compound that could prevent lasting damage from traumatic brain injury and stroke; the drug is currently in clinical trials. The firm is also developing Dexanabinol as a possible therapy for multiple sclerosis and other CNS and inflammatory conditions.

 COMPETITION
Allergan, Inc. (AGN)
Novartis AG (NVS)
Schering AG (SHR)

 STOCK ANALYSIS
 View by:
 Day 
 Day 
 Month 
 Month 
 Year 
 Year 
FURTHER ANALYSIS
• Advanced Charting
• Deals

 FINANCIAL OVERVIEW
Fiscal Year-End: December
2000 Sales (mil.): 5.10
1-Yr. Sales Growth: 54.5%
Employees: 66
Revenue per employee: $77,272.73

 KEY PEOPLE
• Haim Aviv
    CEO
• Robert W. Cook
    CFO

 CONTACT INFO
99 Wood Ave. South, Ste. 301
Iselin, NJ 08830
US
Phone: 732-452-9556
Fax: 732-452-9557
Online: Web Site

Company Data   News, quotes & more       

Hoovers Online   Hoover's Company Capsule
Copyright © 2001, Hoover's Inc. Austin, Texas.
For changes and updates, contact Hoover's directly.


ADVERTISEMENT
FEATURED LINKS
Home |  Customer Service |  About Us
Australia |  Brazil |  China |  Korea |  Norway |  Poland |  Sweden |  Taiwan

Copyright ©2001 Standard Media International. Privacy Policy
Stock data provided by Stockpoint and its data suppliers. Copyright © 1995-2001